Source link : https://www.newshealth.biz/health-news/fda-approves-second-generic-daily-glp-1-drug-for-t2d/
The US Food and Drug Administration has approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor agonist (GLP-1 RA) liraglutide (Victoza, Novo Nordisk) to lower blood sugar in people aged 10 years or older with type 2 diabetes (T2D), as an adjunct to diet and exercise. The move follows the FDA’s approval last […]
Author : News Health
Publish date : 2024-12-23 20:36:02
Copyright for syndicated content belongs to the linked Source.
inHealth